Recent in silico studies identified EGR3 as a central gene in a network of transcription factors and microRNAs associated with schizophrenia risk [2], a master regulator of genes that are differentially regulated in bipolar disorder patients [3], and a critical regulator of DEGs involved in synaptic function in Alzheimer’s disease [4]. The gene discussed is EGR3; the disease is schizophrenia.